peng xu
School of Medicine, Yale University
New Haven, United States
Review Editor
Cancer Immunity and Immunotherapy
Editors
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
pengfei xu
University of California, Davis
Davis, United States
Review Editor
Cancer Immunity and Immunotherapy
rong xu
University of Liverpool
Liverpool, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
xiaogang xu
Zhejiang University
Hangzhou, China
Review Editor
Cancer Immunity and Immunotherapy
xiaopan xu
Air Force Medical University
Xi'an, China
Review Editor
Cancer Immunity and Immunotherapy
yang xu
Southern University of Science and Technology
Shenzhen, China
Review Editor
Cancer Immunity and Immunotherapy
yingkun xu
Qilu Hospital, Shandong University
Jinan, China
Review Editor
Cancer Immunity and Immunotherapy
zi-jun xu
Josep Carreras Leukaemia Research Institute
Barcelona, Spain
Review Editor
Cancer Immunity and Immunotherapy
kai xue
Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, China
Review Editor
Cancer Immunity and Immunotherapy
shigeki yagyu
Kyoto Prefectural University of Medicine
Kyoto, Japan
Review Editor
Cancer Immunity and Immunotherapy
takeshi yamada
Ehime Prefectural University of Health Science
Tobe, Japan
Review Editor
Cancer Immunity and Immunotherapy
hisakazu yamagishi
Kyoto Prefectural University
Kyoto, Japan
Review Editor
Cancer Immunity and Immunotherapy
chi yan
Genome Prairie, Max Rady College of Medicine, University of Manitoba
Saskatoon, Canada
Review Editor
Cancer Immunity and Immunotherapy
hengxiu yan
Southwest Minzu University
Chengdu, China
Review Editor
Cancer Immunity and Immunotherapy
juming yan
Xuzhou Medical University
Xuzhou, China
Review Editor
Cancer Immunity and Immunotherapy
jun yan
Beijing Institute for Brain Disorders, Capital Medical University
Beijing, China
Review Editor
Cancer Immunity and Immunotherapy